IL2RA and COVID-19: Patients with moderate and severe COVID-19 usually show a marked increase in their (serum) levels of IL-6, TNF-α, IL-2R, IL-10, and other inflammation-related markers such as high-sensitivity C-reactive protein, D-dimer, and ferritin (Ye et al., 2020).